Literature DB >> 23102268

Mass production of nanofibrous extracellular matrix with controlled 3D morphology for large-scale soft tissue regeneration.

Mohammad A Alamein1, Sebastien Stephens, Qin Liu, Stuart Skabo, Patrick H Warnke.   

Abstract

AIM: Biomaterials that mimic the nanofibrous architecture of the natural extracellular matrix (ECM) are in the focus for stem cell hosting or delivery in tissue engineering of multilayered soft tissues such as skin, mucosa, or retina. Synthetic nanofibers for such ECM are usually produced by single-syringe electrospinning with only one needle-jet at very low production rates of 0.005-0.008 g·min⁻¹. The aim of this study was to utilize a novel industrial needle-free multijet electrospinning device with the potential for mass production of nanofibrous ECM (NF-ECM) exhibiting a controlled three-dimensional (3D) morphology for large-scale applications such as large area skin regeneration in patients with burns.
METHODS: The novel NanoSpider™ NS200, an industrial apparatus originally designed for electrospinning of nanofibrous textile meshes, was used to fabricate 3D NF-ECMs of the following synthetic and natural biopolymers: collagen, gelatin, poly(caprolactone) (PCL), and poly(L-lactide-co-glycolide) (PLGA). Different concentrations of Gelatin polymer solution were electrospun under varying processing conditions, namely speed of spinning electrode rotation (u) and electric field intensity (E) by altering applied voltage (v) or the distance between electrodes (h) to achieve homogeneous desirable 3D morphology. Nanofiber diameters were assessed by scanning electron microscopy (SEM). Biocompatibility was tested by WST-1 (water-soluble tetrazolium salt) proliferation assay of seeded human mesenchymal stem cells (HMSCs). Biological performance of HMSCs on 3D PLGA NF-ECM was compared to two-dimensional (2D) PLGA film controls via SEM and confocal microscopy. Western blotting addressed the expression of surface adhesion proteins; focal adhesion kinase (FAK), phosphorylated FAK (pY397), α-tubulin, paxillin, vinculin. and integrin subunits; α5, αv, and β1 proteins.
RESULTS: Large-scale mass production of NF-ECM membranes with a highly homogenous nanofiber morphology and 3D architecture could be produced with an extremely high production rate of 0.394±0.013 g·min⁻¹·m⁻¹ when compared to standard procedures. This was achieved by electrospinning a 20% (wt)/v gelatin solution, in an electric field intensity of 0.381 kV·mm⁻¹. The nanofibers possessed diameters of around 180±40 nm with 28% deviation. HSMCs proliferation was significantly improved on NF-ECMs derived from collagen, gelatin, and PLGA when compared to PCL or flat coverglass controls (p<0.01). PLGA NF-ECM in 3D nanofibrous architecture possessed significantly superior biocompatibility when compared to flat 2D PLGA film (p<0.05). Furthermore, on 3D PLGA NF-ECMs, HSMCs expressed a higher amount of α-tubulin and paxillin compared to the HMSCs cultured on a 2D PLGA film (p<0.05). HMSCs exhibited a complex multifaceted morphology on all NF-ECMs, where cells appeared to be integrated into the 3D NF-ECMs niches with complex cell filopodia extending into to all directions. In contrast, HMSCs on flat 2D films of the same materials or on coverglass displayed a simple flattened, monolayered structure.
CONCLUSION: Needle-free multijet electrospinning can be used to mass produce artificial ECMs with intrinsic biocompatibility and desirable integration of stem cells for large-scale applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102268     DOI: 10.1089/ten.TEC.2012.0417

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  9 in total

1.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 2.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

3.  Electrospun gelatin/polycaprolactone nanofibrous membranes combined with a coculture of bone marrow stromal cells and chondrocytes for cartilage engineering.

Authors:  Xiaomin He; Bei Feng; Chuanpei Huang; Hao Wang; Yang Ge; Renjie Hu; Meng Yin; Zhiwei Xu; Wei Wang; Wei Fu; Jinghao Zheng
Journal:  Int J Nanomedicine       Date:  2015-03-17

4.  A comparative evaluation of the effect of polymer chemistry and fiber orientation on mesenchymal stem cell differentiation.

Authors:  David C L Rowland; Thomas Aquilina; Andrei Klein; Osnat Hakimi; Pierre Alexis-Mouthuy; Andrew J Carr; Sarah J B Snelling
Journal:  J Biomed Mater Res A       Date:  2016-07-20       Impact factor: 4.396

Review 5.  Aloe Vera for Tissue Engineering Applications.

Authors:  Shekh Rahman; Princeton Carter; Narayan Bhattarai
Journal:  J Funct Biomater       Date:  2017-02-14

6.  Scaling-Up Techniques for the Nanofabrication of Cell Culture Substrates via Two-Photon Polymerization for Industrial-Scale Expansion of Stem Cells.

Authors:  Davide Ricci; Michele M Nava; Tommaso Zandrini; Giulio Cerullo; Manuela T Raimondi; Roberto Osellame
Journal:  Materials (Basel)       Date:  2017-01-13       Impact factor: 3.623

7.  Fabrication of transparent hemispherical 3D nanofibrous scaffolds with radially aligned patterns via a novel electrospinning method.

Authors:  Jeong In Kim; Ju Yeon Kim; Chan Hee Park
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

Review 8.  Tissue engineering in female pelvic floor reconstruction.

Authors:  Xiaotong Wu; YuanYuan Jia; Xiuli Sun; Jianliu Wang
Journal:  Eng Life Sci       Date:  2020-04-14       Impact factor: 2.678

Review 9.  Natural hydrogels R&D process: technical and regulatory aspects for industrial implementation.

Authors:  Marta Calvo Catoira; Javier González-Payo; Luca Fusaro; Martina Ramella; Francesca Boccafoschi
Journal:  J Mater Sci Mater Med       Date:  2020-07-21       Impact factor: 3.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.